1-(3,4-dichlorophenyl)-4,4-dimethyl-7-(2-methyloctan-2-yl)-1,4-dihydrochromeno[4,3-c]pyrazol-9-ol

ID: ALA4483721

PubChem CID: 135936180

Max Phase: Preclinical

Molecular Formula: C27H32Cl2N2O2

Molecular Weight: 487.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)c1cnn(-c3ccc(Cl)c(Cl)c3)c1-2

Standard InChI:  InChI=1S/C27H32Cl2N2O2/c1-6-7-8-9-12-26(2,3)17-13-22(32)24-23(14-17)33-27(4,5)19-16-30-31(25(19)24)18-10-11-20(28)21(29)15-18/h10-11,13-16,32H,6-9,12H2,1-5H3

Standard InChI Key:  AEDDUCGDZOJJSE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   18.9151   -6.5251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5106   -5.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1017   -6.5226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5732   -6.1207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9860   -5.4149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1684   -5.4104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6912   -5.8194    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3965   -4.5977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3949   -5.4131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0991   -5.8204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8054   -5.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8031   -4.5949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0983   -4.1913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9899   -4.5955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6912   -4.1850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5176   -3.3911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7088   -3.3109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3828   -4.0552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0963   -3.3742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2209   -5.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9290   -5.8199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6363   -5.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3444   -5.8185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0517   -5.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7598   -5.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0613   -2.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8624   -2.9507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4054   -2.3410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1485   -1.5644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3435   -1.4009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8040   -2.0119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0837   -0.6286    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.6909   -0.9531    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
 14  5  1  0
  5  7  1  0
  7  9  1  0
  8 15  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 13 19  1  0
 11  2  1  0
  2 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 16 26  1  0
 30 32  1  0
 29 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4483721

    ---

Associated Targets(Human)

CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.47Molecular Weight (Monoisotopic): 486.1841AlogP: 8.43#Rotatable Bonds: 7
Polar Surface Area: 47.28Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.00CX Basic pKa: 0.91CX LogP: 8.59CX LogD: 8.58
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.34Np Likeness Score: -0.27

References

1. Morales P, Gómez-Cañas M, Navarro G, Hurst DP, Carrillo-Salinas FJ, Lagartera L, Pazos R, Goya P, Reggio PH, Guaza C, Franco R, Fernández-Ruiz J, Jagerovic N..  (2016)  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.,  59  (14): [PMID:27309150] [10.1021/acs.jmedchem.6b00397]

Source